Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: A phase 4 trial
Author(s) -
Ana Cristina de Medeiros Ribeiro,
Nádia Emi Aikawa,
Carla Gonçalves Schahin Saad,
Emily Figueiredo Neves Yuki,
Tatiana do Nascimento Pedrosa,
Solange Fusco,
Priscila T. Rojo,
Rosa Maria Rodrigues Pereira,
Samuel Katsuyuki Shinjo,
Danieli Andrade,
Percival D. SampaioBarros,
Carolina Torres Ribeiro,
Giordano B. H. Deveza,
Victor A. O. Martins,
Clóvis A. Silva,
Marta Heloísa Lopes,
Alberto J. S. Duarte,
Leila Antonângelo,
Éster Cerdeira Sabino,
Esper G. Kallás,
Sandra Gofinet Pasoto,
Eloísa Bonfá
Publication year - 2021
Publication title -
sbr 2021 congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2021.1852
Subject(s) - immunogenicity , medicine , immunology , virology , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom